View Exam | PowerPak

1. Which of these characteristics best reflects the clinical presentation of breakthrough cancer pain?

A. Rapid onset, short duration B. Rapid onset, long duration C. Short duration, low pain intensity D. High pain intensity, poorly controlled baseline pain

2. PT is a 62-year-old female with breast cancer. Despite well-controlled baseline pain, she reports frequent episodes of BTCP that are severe in intensity, typically lasting for 10 to 15 minutes. When asked about precipitating factors, PT states that the episodes are spontaneous and unpredictable with no known triggers. Which of the following would be the best therapeutic option at this time?

A. Oral morphine B. High-dose nonsteroidal anti-inflammatory drugs C. Transmucosal fentanyl D. Oral oxycodone

3. Which medications are considered first-line therapy for refractory neuropathic breakthrough cancer pain among patients who do not suffer from comorbid depression?

A. Anticholinergics B. Antidepressants C. Bisphosphonates D. Anticonvulsants

4. RS is a 55-year-old male with prostate cancer who suffers from frequent episodes of breakthrough cancer pain. Although fentanyl has proven somewhat effective for him, increasing its dosage would help optimize pain control. However, RS has been experiencing significant sedation and is worried that this may become intolerable. Which of the following agents may be a useful adjuvant medication for RS enabling him to increase opioid doses?

A. Zoledronic acid B. Methylphenidate C. Ketamine D. Duloxetine

5. Which of the following features is characteristic of pseudoaddiction and distinguishes it from addiction?

A. Compulsive drug use B. Drug use despite harm C. Pursuit of opioid therapy for pain relieving effects D. Impaired control over drug use

6. All of the following are strategies that may be used to optimize pharmacist-patient communication, EXCEPT:

A. Using medical terminology to ensure professional education B. Focusing on key messages and repeating key points C. Soliciting questions by speaking in an open-ended manner D. Using a “teach-back” technique to assess recall

7. Breakthrough cancer pain has been reported to cause all of the following, EXCEPT:

A. Sleep disturbances B. Reductions in the frequency of healthcare provider visits C. Economic hardships D. Disruptions in family relationships

8. Which of the following has not been cited as a reason for the undertreatment of breakthrough cancer pain?

A. Fear of opioid abuse B. Concerns regarding adverse effects C. Shortcomings in medical training D. Minimal pain intensity

9. Which of the following transmucosal fentanyl formulations presents fentanyl in a layer that adheres to the inside of the patient's cheek and contains an outer layer that isolates the fentanyl-containing layer from the saliva, thereby minimizing swallowing and loss during first-pass metabolism?

A. Fentanyl buccal soluble film B. Oral transmucosal fentanyl citrate C. Sublingual fentanyl D. Fentanyl buccal tablets

10. Which of these is not an important aspect of pharmacist counseling when it comes to managing patients with breakthrough cancer pain?

A. Explaining the importance of effective communication B. Assessing patients' background knowledge to engage in a constructive discussion regarding drug therapy C. Emphasizing that BTCP is common and that there are several agents available that can safely and effectively relieve pain D. Explaining how easily patients may become addicted to opioid therapy

Maintenance is scheduled for 05/16/2024 5:00 PM EST - 05/17/2024 5:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of these characteristics best reflects the clinical presentation of breakthrough cancer pain?

3. Which medications are considered first-line therapy for refractory neuropathic breakthrough cancer pain among patients who do not suffer from comorbid depression?

5. Which of the following features is characteristic of pseudoaddiction and distinguishes it from addiction?

6. All of the following are strategies that may be used to optimize pharmacist-patient communication, EXCEPT:

7. Breakthrough cancer pain has been reported to cause all of the following, EXCEPT:

8. Which of the following has not been cited as a reason for the undertreatment of breakthrough cancer pain?

9. Which of the following transmucosal fentanyl formulations presents fentanyl in a layer that adheres to the inside of the patient's cheek and contains an outer layer that isolates the fentanyl-containing layer from the saliva, thereby minimizing swallowing and loss during first-pass metabolism?

10. Which of these is not an important aspect of pharmacist counseling when it comes to managing patients with breakthrough cancer pain?

« Return to Activity

Maintenance is scheduled for 05/16/2024 5:00 PM EST - 05/17/2024 5:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of these characteristics best reflects the clinical presentation of breakthrough cancer pain?

3. Which medications are considered first-line therapy for refractory neuropathic breakthrough cancer pain among patients who do not suffer from comorbid depression?

5. Which of the following features is characteristic of pseudoaddiction and distinguishes it from addiction?

6. All of the following are strategies that may be used to optimize pharmacist-patient communication, EXCEPT:

7. Breakthrough cancer pain has been reported to cause all of the following, EXCEPT:

8. Which of the following has not been cited as a reason for the undertreatment of breakthrough cancer pain?

9. Which of the following transmucosal fentanyl formulations presents fentanyl in a layer that adheres to the inside of the patient's cheek and contains an outer layer that isolates the fentanyl-containing layer from the saliva, thereby minimizing swallowing and loss during first-pass metabolism?

10. Which of these is not an important aspect of pharmacist counseling when it comes to managing patients with breakthrough cancer pain?

« Return to Activity

Customers who Purchased
this Activity also Purchased